artemisinin has been researched along with Leishmaniasis, Visceral in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afrin, F; Chattopadhyay, AP; Chouhan, G; Dasgupta, AK; Islamuddin, M; Want, MY | 1 |
| Afrin, F; Chattopadhyay, AP; Chouhan, G; Dasgupta, AK; Hemeg, HA; Islamuddin, M; Ozbak, HA; Want, MY | 1 |
| Chatterjee, M; Ganguly, S; Saha, P; Sen, R | 1 |
| Liu, Y | 1 |
1 review(s) available for artemisinin and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Chemotherapy of parasitic diseases. Current status and new directions.
Topics: Amphotericin B; Antimalarials; Antiprotozoal Agents; Artemisinins; Humans; Leishmaniasis, Visceral; Malaria, Falciparum; Parasitic Diseases; Praziquantel; Schistosomiasis japonica; Schistosomicides; Sesquiterpenes | 1996 |
3 other study(ies) available for artemisinin and Leishmaniasis, Visceral
| Article | Year |
|---|---|
A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Lactic Acid; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
Topics: Animals; Anti-Infective Agents; Antibodies, Protozoan; Artemisia; Artemisinins; B7-1 Antigen; Cell Proliferation; Cytokines; Female; Hypersensitivity, Delayed; Leishmania donovani; Leishmaniasis, Visceral; Liver; Lymphocytes; Macrophages, Peritoneal; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanoparticles; Organ Size; Spleen; Treatment Outcome | 2015 |
Efficacy of artemisinin in experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Disease Models, Animal; Humans; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Spleen; Treatment Outcome | 2010 |